WuXi Biologics WKN: A2QJCN ISIN: KYG970081173 Forum: Aktien User: Summer.76

Hm, scheint eine stabile Anlage zu sein...haben die konkret heiße Eisen im Feuer, da der Kurs so abgeht? oÔ

Wegen der Feiertage war heute nur verkürzter Handel in HK. Weiter geht es dort dann wieder am Dienstag.

Meines Erachtens sollte das durch sein, aber schau sonst noch mal in die Meldung von Anfang Februar.

Bekommt man als derzeitiger Aktionär Kaufoptionen ?

WuXi Biologics (02269.HK) allots 118 million shares https://m.jrj.com.cn/madapter/hk/2021/02/10164031883743.shtml WuXi Biologics (02269.HK) announced that it will allot and issue 1.18 on February 10, 2021 in accordance with the general authorization to place new shares as disclosed in the company’s announcement dated February 3, 2021 100 million shares at an issue price of HK$112 per share. https://doc.irasia.com/listco/hk/wuxibiologics/announcement/a210210.pdf

The World's Largest 36,000L Biomanufacturing Line Using Single-use Bioreactors Launches GMP Operation at WuXi Biologics https://www.prnewswire.com/news-releases/the-worlds-largest-36-000l-biomanufacturing-line-using-single-use-bioreactors-launches-gmp-operation-at-wuxi-biologics-301224382.html • Greatly increase the company's current capacity to 90,000L and enable WuXi Biologics to initiate any project within four weeks • Offer flexible large-scale manufacturing services by implementing Scale-out strategy ...

Guten Morgen, 2 verkürzte Handelswochen stehen bevor, da Freitag und kommenden Montag die Börse in Hongkong geschlossen hat. Hier läuft der Handel natürlich weiter. Einen guten Wochenstart 🍀

Daiwa Restates Buy on WUXI BIO (02269.HK), TP $135: Better Captures COVID-19 Vaccine Demands post Placing http://www.aastocks.com/en/stocks/news/aafn-con/NOW.1073972/company-news Daiwa mentioned in its research report that WUXI BIO (02269 HK) had announced the fourth round of new share placement, from which the drugmaker can strengthen the fiscal position to better seize the potential outsourcing demands of mRNA-based vaccines against novel coronavirus. The broker restated Buy on WUXI BIO at the target price $135.

Hang Seng Index retreats as regulatory risks hurt Alibaba and WuXi Biologics plans new stock placement at discount https://amp.scmp.com/business/markets/article/3120316/hong-kong-stocks-drop-regulatory-risks-hurt-alibaba-and-wuxi • Hang Seng Index snaps a two-day advance amid uncertainty surrounding antitrust probes, Ant Group IPO revival • WuXi Biologics slips after company plans HK$13.2 billion (US$1.69 billion) stock placement at a discount to market price ... WuXi Biologics fell 2.2 per cent to HK$117.80. The Chinese drug developer announced late Tuesday a plan to raise HK$13.2 billion (US$1.69 billion) by selling 118 million new shares at HK$112 each, or about 7 per cent below the market price. ...

Nicht immer nur gute News, aber dafür ists ja auch Börse 😉

WuXi Biologics (02269 HK) shares 6.1%-8.2% discount to raise up to 9.94 billion yuan http://www.aastocks.com/tc/stocks/news/aafn-news/NOW.1073759/2 According to Reuters' IFR report, WuXi Biologics proposed placement of 88 million shares, accounting for 2.1% of the enlarged share capital, raising a maximum of 9.94 billion yuan. The placing price is between 110.5-113 yuan per share, which is based on today's closing price of 120.4 Calculated in yuan, the discount is 6.1%-8.2%, and a six-month lock-up period will be set. 

👌👌

Gerne! Freut mich, wenn die Infos wieder hilfreich waren.

Wird wieder mal Zeit für ein dickes Dankeschön fürs Teilen der ganzen Informationen, Summer.76😊👍🏼

Antengene Announces Collaboration with WuXi Biologics and WuXi STA to Advance Antibody-Drug Conjugate Candidate into Clinical-stage https://finance.yahoo.com/amphtml/news/antengene-announces-collaboration-wuxi-biologics-000900621.html#aoh=16121610720048&referrer=https%3A%2F%2Fwww.google.com&amp_tf=Von%20%251%24s

Goldman ups Wuxi Biologics (02269) to HK$128.6 https://www.etnet.com.hk/www/tc/news/categorized_news_detail_eng.php?newsid=ETE310129132